iLabtest LLC is a wholly owned subsidiary of Essenlix. iLabtest Model X and U are based on the sample working principle of the iMOST (instant Mobile Self Test) Model X and U invented and developed at Essenlix Corporation iMOST Model X-1 for CBC has received a CE Mark for human diagnostics.

Essenlix, a digital health and wellness company, originating from Princeton University, founded in late 2013, develops a game-changing lab testing system, iMOST. Essenlix was founded in 2013 by Dr. Stephen Chou and Dr. Lin Chou. Stephen Chou, Joseph C. Elgin Professor of Engineering at Princeton University, Member of National Academy of Engineering, National Academy of Invention and a serial entrepreneur, is one of the world’s leading nanotechnology experts with deep experience in bioengineering and sensors as well as clinical diagnostics (https://ece.princeton.edu/people/stephen-chou).

To develop its proprietary iMOST/iLabtest platform, Essenlix has brought together a multidisciplinary, albeit unconventional, technical team of industry, healthcare and academia veterans, covering bio-engineering, nanotechnology, advanced imaging, artificial intelligence, machine learning, and medicine, in addition to its business and manufacturing team.